GT Biopharma, Inc DEFA14A, filed May 5, 2023
GT Biopharma, Inc. (GTBP)
DEFA14A
2023-05-05
View Original
Added on
October 15, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
| Filed by the registrant ☒ | Filed by a Party other than the Registrant ☐ |
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | ☐ | Confidential, For Use | |
| ☐ | Definitive Proxy Statement | of the Commission Only | ||
| ☒ | Definitive Additional Materials | (as permitted by Rule | ||
| ☐ | Soliciting Material under Rule 14a-12 | 14a-6(e)(2)) |
GT BIOPHARMA, INC.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No Fee Required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
